ORKA Oruka Therapeutics, Inc.
Healthcare$60.61+3.27%ClosedMarket Cap: $2.27B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$136.38
Target (Median)
$135.50
Target Range
$75.00 - $200.00
Upside from current price: 125.0%
Rating Distribution
2 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-14 | BTIG | maintain | Buy | Buy |
| 2026-04-28 | Barclays | maintain | Overweight | Overweight |
| 2026-04-28 | UBS | maintain | Buy | Buy |
| 2026-04-15 | Wedbush | maintain | Outperform | Outperform |
| 2026-04-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-13 | BTIG | maintain | Buy | Buy |
| 2026-04-13 | Guggenheim | maintain | Buy | Buy |
| 2026-03-16 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-03-13 | Wedbush | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.49 | $0.00 | 8 |
| Sun Dec 31 | $-3.38 | $0.00 | 7 |
| Mon Dec 31 | $-4.26 | $0.00 | 2 |
| Tue Dec 31 | $-4.76 | $75.6M | 5 |